VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $11,512,000 | -19.6% | 723,123 | +4.9% | 0.06% | -19.7% |
| Q4 2017 | $14,320,000 | +43.4% | 689,136 | -1.1% | 0.07% | +39.2% |
| Q3 2017 | $9,983,000 | +39.2% | 696,661 | +68.0% | 0.05% | +30.8% |
| Q2 2017 | $7,173,000 | +30.8% | 414,646 | -16.6% | 0.04% | +62.5% |
| Q1 2017 | $5,485,000 | +75.4% | 497,272 | +130.9% | 0.02% | +50.0% |
| Q4 2016 | $3,127,000 | -54.5% | 215,339 | -23.0% | 0.02% | -50.0% |
| Q3 2016 | $6,869,000 | +60.3% | 279,786 | +31.5% | 0.03% | +45.5% |
| Q2 2016 | $4,286,000 | -6.6% | 212,797 | +22.0% | 0.02% | -29.0% |
| Q1 2016 | $4,587,000 | -70.6% | 174,419 | +13.5% | 0.03% | -75.0% |
| Q4 2015 | $15,618,000 | +33.1% | 153,641 | +133.5% | 0.12% | +37.8% |
| Q3 2015 | $11,737,000 | -30.7% | 65,795 | -13.7% | 0.09% | -10.0% |
| Q2 2015 | $16,932,000 | +12.4% | 76,219 | +0.5% | 0.10% | +14.9% |
| Q1 2015 | $15,069,000 | +16.8% | 75,866 | -15.9% | 0.09% | +8.8% |
| Q4 2014 | $12,904,000 | +3.2% | 90,168 | -5.4% | 0.08% | +21.2% |
| Q3 2014 | $12,505,000 | +14.6% | 95,315 | +10.1% | 0.07% | +32.0% |
| Q2 2014 | $10,915,000 | -15.9% | 86,546 | -12.1% | 0.05% | -21.9% |
| Q1 2014 | $12,984,000 | +3.4% | 98,488 | -7.9% | 0.06% | +1.6% |
| Q4 2013 | $12,560,000 | +11.8% | 106,984 | -0.6% | 0.06% | +10.5% |
| Q3 2013 | $11,234,000 | +16.8% | 107,676 | -3.6% | 0.06% | +9.6% |
| Q2 2013 | $9,615,000 | – | 111,702 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |